Oribel Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,100
Closed -$5.3M 154
2026
Q1
$5.3M Buy
+25,100
New +$5.41M 0.23% 100
2025
Q4
Sell
-377,100
Closed -$59.2M 114
2025
Q3
$59.2M Sell
377,100
-15,300
-4% -$2.36M 1.86% 16
2025
Q2
$65.9M Sell
392,400
-439,200
-53% -$65.2M 1.68% 14
2025
Q1
$115M Buy
831,600
+404,900
+95% +$51.6M 4.69% 1
2024
Q4
$50.5M Buy
+426,700
New +$49.8M 1.72% 20
2023
Q2
Sell
-200,300
Closed -$7.24M 77
2023
Q1
$7.24M Buy
+200,300
New +$15.1M 0.65% 62

Other funds holding CAH

Oribel Capital Management's CAH Position: Q2 2026 in Review

Oribel Capital Management sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 25,100 shares — an estimated $5.3M sold.

Oribel Capital Management first reported a position in CAH in Q1 2023 and held it in 6 quarters. The position peaked at $115M in Q1 2025. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Oribel Capital Management reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Oribel Capital Management sold 25,100 Cardinal Health shares in Q2 2026, an estimated $5.3M.
  • Oribel Capital Management first reported a position in Cardinal Health in Q1 2023 and held it in 6 quarters.
  • Oribel Capital Management's Cardinal Health position peaked at $115M in Q1 2025.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Oribel Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.